Skip to Content
You are currently on the new version of our website. Access the old version .
CancersCancers
  • Article
  • Open Access

1 September 2019

10 Pages

Near-Infrared Fluorescent Sorbitol Probe for Targeted Photothermal Cancer Therapy

,
,
,
,
and
1
Department of Otolaryngology-Head and Neck Surgery, Chonnam National University Hwasun Hospital and Medical School, Hwasun 58128, Korea
2
Department of Biomedical Sciences, Chonnam National University Medical School, Hwasun 58128, Korea
3
Institute of Cell and Tissue Engineering, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
4
Department of Surgery, Chonnam National University Hwasun Hospital and Medical School, Hwasun 58128, Korea

Abstract

Photothermal therapy (PTT) using a near-infrared (NIR) heptamethine cyanine fluorophore has emerged as an alternative strategy for targeted cancer therapy. NIR fluorophores showing a high molar extinction coefficient and low fluorescence quantum yield have considerable potential applications in photothermal cancer therapy. In this study, a bifunctional sorbitol–ZW800 conjugate was used as an advanced concept of photothermal therapeutic agents for in vivo cancer imaging and therapy owing to the high tumor targetability of the sorbitol moiety and excellent photothermal property of NIR heptamethine cyanine fluorophore. The sorbitol–ZW800 showed an excellent photothermal effect increased by 58.7 °C after NIR laser irradiation (1.1 W/cm2) for 5 min. The HT-29 tumors targeted by sorbitol–ZW800 showed a significant decrease in tumor volumes for 7 days after photothermal treatment. Therefore, combining the bifunctional sorbitol–ZW800 conjugate and NIR laser irradiation is an alternative way for targeted cancer therapy, and this approach holds great promise as a safe and highly efficient NIR photothermal agent for future clinical applications.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.